Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-05-26Clinical Trial Update: A Study of Bendamustine in the Treatment of Chinese Participants With Indolent Non-Hodgkin Lymphoma Refractory to Rituximab Treatment [Phase 3]
A Phase 3 trial evaluating bendamustine in Chinese patients with rituximab-refractory indolent non-Hodgkin lymphoma has completed with resul…
-
CLINICAL_TRIALS trial_result · 2023-05-25Clinical Trial Update: Mega-CHOEP: Conventional Chemo Vs HD Chemo Followed by Auto SCT in Younger Pts With Aggressive Non-Hodgkin's Lymphoma [Phase 3]
Phase 3 trial comparing conventional chemotherapy to high-dose chemotherapy with autologous stem cell transplant in younger patients with ag…
-
CLINICAL_TRIALS trial_result · 2023-05-16Clinical Trial Update: Ulixertinib in Treating Patients With Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) [Phase 2]
Phase 2 Pediatric MATCH trial evaluating Ulixertinib for MAPK-pathway-mutant tumors in children, including advanced solid tumors, Non-Hodgki…
-
CLINICAL_TRIALS trial_result · 2023-04-27Clinical Trial Update: Tazemetostat in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With EZH2, SMARCB1, or SMARCA4 Gene Mutations (A Pediatric MATCH Treatment Trial) [Phase 2]
This Phase 2 pediatric MATCH trial update reports results for tazemetostat in patients with relapsed or refractory solid tumors, non-Hodgkin…
-
CLINICAL_TRIALS trial_result · 2023-04-27Clinical Trial Update: Reduced Intensity Conditioning Transplant Using Haploidentical Donors [Phase 2]
Phase 2 clinical trial investigating reduced intensity conditioning transplant using haploidentical donors for various hematologic malignanc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Acalabrutinib With Rituximab and Lenalidomide in Relapsed/Refractory B-cell Non-Hodgkin Lymphoma [Phase 2]
Phase 2 trial evaluating acalabrutinib with rituximab and lenalidomide in relapsed/refractory B-cell non-Hodgkin lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-14Clinical Trial Update: Clinical Trial to Evaluate CD19 CAR T (CT032) in Patients With Relapsed and/or Refractory Non-Hodgkin's B Cell Lymphoma [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating CD19 CAR T (CT032) in relapsed or refractory non-Hodgkin B-cell lymphoma has completed.
-
CLINICAL_TRIALS trial_result · 2023-04-12Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Efficacy of AMG 397 in Subjects With Selected Relapsed or Refractory Hematological Malignancies [Phase 1]
Phase 1 trial updating safety, tolerability, pharmacokinetics, and efficacy of AMG 397 in relapsed or refractory hematological malignancies;…
-
CLINICAL_TRIALS trial_result · 2023-03-29Clinical Trial Update: Intrathecal Rituximab With Standard Intrathecal Prophylaxis to Prevent CNS Relapse for CD 20+ Non Hodgkin Lymphoma [Phase 2]
A Phase 2 clinical trial evaluates intrathecal rituximab combined with standard intrathecal prophylaxis to prevent CNS relapse in CD20+ non-…
-
CLINICAL_TRIALS trial_result · 2023-03-21Clinical Trial Update: Bortezomib and Gemcitabine in Treating Patients With Relapsed B-Cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]
Clinical trial update for bortezomib and gemcitabine in relapsed B-cell non-Hodgkin lymphoma (Phase 1/Phase 2) completed with results posted…
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: A Study Evaluating a Proprietary Amino Acid Mixture (Enterade®) in Patients Receiving High-Dose Melphalan Conditioning Followed by Autologous Stem Cell Transplantation for Multiple Myeloma and Non-Hodgkin Lymphoma [NA]
A completed clinical trial evaluating an amino acid mixture (Enterade) used during high-dose melphalan conditioning prior to autologous stem…
-
CLINICAL_TRIALS trial_result · 2023-03-16Clinical Trial Update: TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia [Phase 1, Phase 2]
Phase 1/2 trial update for TC-110 T cells in adults with relapsed or refractory non-Hodgkin lymphoma or acute lymphoblastic leukemia (comple…
-
CLINICAL_TRIALS trial_result · 2023-03-07Clinical Trial Update: An Investigational Immuno-therapy Safety and Effectiveness Study of Nivolumab in Combination With Brentuximab Vedotin to Treat Non-Hodgkin Lymphomas [Phase 1, Phase 2]
Phase 1/2 trial evaluating nivolumab plus brentuximab vedotin for non-Hodgkin lymphoma completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-02-09Clinical Trial Update: Vincristine Sulfate Liposome Injection (Marqibo®), Bendamustine and Rituximab-Phase I Trial in Indolent B-cell Lymphoma [Phase 1]
Phase I trial evaluating a combination of Vincristine Sulfate Liposome Injection with Bendamustine and Rituximab in indolent B-cell lymphoma…
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Dose-escalation Study of Safety of PBCAR20A in Subjects With r/r NHL or r/r CLL/SLL [Phase 1, Phase 2]
Dose-escalation early-stage trial assessing safety of PBCAR20A in relapsed/refractory Non-Hodgkin's Lymphoma and relapsed/refractory Chronic…
-
CLINICAL_TRIALS trial_result · 2023-01-31Clinical Trial Update: Tac, Mini-MTX, MMF Versus Tac, MTX for GVHD Prevention [Phase 3]
Phase 3 trial comparing Tacrolimus plus mini-methotrexate versus Tacrolimus plus methotrexate for graft-versus-host disease prevention has c…
-
CLINICAL_TRIALS trial_result · 2023-01-23Clinical Trial Update: Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis [Phase 2]
Phase 2 trial of adoptive immunotherapy in relapsed hematological malignancies with early GVHD prophylaxis has completed enrollment and post…
-
CLINICAL_TRIALS trial_result · 2023-01-20Clinical Trial Update: Japanese Phase Ib/II Copanlisib in Relapsed, Indolent B-cell NHL [Phase 1, Phase 2]
Phase Ib/II trial updates for copanlisib in relapsed, indolent B-cell non-Hodgkin lymphoma conducted in Japan.
-
CLINICAL_TRIALS trial_result · 2023-01-10Clinical Trial Update: Nivolumab With or Without Ipilimumab in Treating Younger Patients With Recurrent or Refractory Solid Tumors or Sarcomas [Phase 1, Phase 2]
Phase 1/2 trial evaluating nivolumab with or without ipilimumab in younger patients with recurrent or refractory solid tumors or sarcomas; c…
-
CLINICAL_TRIALS trial_result · 2022-12-29Clinical Trial Update: Lisocabtagene Maraleucel (JCAR017) as Second-Line Therapy (TRANSCEND-PILOT-017006) [Phase 2]
A Phase 2 trial update for lisocabtagene maraleucel (JCAR017) as second-line therapy in non-Hodgkin lymphoma has been completed with results…
-
CLINICAL_TRIALS trial_result · 2022-12-13Clinical Trial Update: Selumetinib Sulfate in Treating Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphoma, or Histiocytic Disorders With Activating MAPK Pathway Mutations (A Pediatric MATCH Treatment Trial) [Phase 2]
A Phase 2 pediatric MATCH trial evaluating selumetinib sulfate in relapsed or refractory advanced solid tumors, non-Hodgkin lymphoma, and hi…
-
CLINICAL_TRIALS trial_result · 2022-12-08Clinical Trial Update: Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematologic Malignancies. [Phase 2]
Phase 2 trial update on conditioning regimens for transplantation of unrelated donor umbilical cord blood in patients with hematologic malig…
-
CLINICAL_TRIALS trial_result · 2022-12-02Clinical Trial Update: A Safety and Efficacy Study of Ibrutinib in Pediatric and Young Adult Participants With Relapsed or Refractory Mature B-cell Non-Hodgkin Lymphoma [Phase 3]
Phase 3 safety and efficacy study of ibrutinib in pediatric and young adult relapsed or refractory mature B-cell non-Hodgkin lymphoma was te…
-
CLINICAL_TRIALS trial_result · 2022-11-30Clinical Trial Update: Zevalin Before Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma [Phase 2]
Phase 2 clinical trial update investigating Zevalin before stem cell transplant in patients with refractory or relapsed non-Hodgkin lymphoma…
-
CLINICAL_TRIALS trial_result · 2022-11-23Clinical Trial Update: Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies [Phase 1, Phase 2]
Phase 1/2 trial update on pralatrexate plus romidepsin in relapsed/refractory lymphoid malignancies and multiple myeloma.